BRCA2 and breast cancer: Similarly, for BRCA2 mutation carriers, the cumulative risk of ovarian cancer by age 80 is 17% (95% CI, 11%-25%), and the cumulative risk of contralateral breast cancer 20 years after a breast cancer diagnosis is 26% (95% CI, 20%-33%) [9].